Market Insights & Analysis


Analyst Coverage According to the analysis of 25 analysts, the consensus is clear: Nike Inc. (NYSE: NKE) is rated as a "Strong Buy." These analysts have set an average target price of USD 120.08 for Nike over the next 12 months. This robust endorsement reflects a collective belief in Nike's potential for significant growth and value appreciation...

NKE

Analyst Ratings Coverage for GIS General Mills Inc. (GIS), a global leader in the food industry, continues to attract attention from analysts as it navigates through market challenges and capitalizes on emerging opportunities. Analyst ratings provide valuable insights for investors, guiding them in making informed decisions. In this article, we...

GIS

US/CDN/UK/IND Ratings Name Symbol Analyst Rating Action Target Price Apple Inc AAPL Wedbush Securities Outperform - Outperform Reiterated by USD 250 Accenture plc ACN Susquehanna International Group Positive - Neutral Downgraded by USD 400 » USD...

Wedbush Reiterates Bullish Stance on Apple Stock: Sets $250 Target with Overweight Rating Wedbush Securities (Analyst Rank #40 ) reaffirmed its bullish stance on Apple Inc. This article delves into Wedbush's latest evaluation, which not only underscores its confidence in Apple's trajectory but also provides investors with a compelling target to...

Global Markets Market Moves Analysis: Wall Street: Wall Street saw an upward trend, buoyed by strong gains in chipmakers, led by Micron Technology. The rally in semiconductor stocks reflected investor optimism surrounding the tech sector, despite ongoing concerns about supply chain disruptions and global chip shortages. Additionally, investors...

 Impact of Social Media Financial Influencers on Retail Investors In recent years, social media platforms have become popular hubs for financial advice and investment discussions. A growing number of self-proclaimed financial influencers leverage these platforms to share their insights, strategies, and stock recommendations with retail...

Biggest Gainers
Price 1 Week Change
USD 11.88
+0.32 (+4.02%)
USD 31.41
+0.10 (+0.42%)
USD 19.09
+0.40 (+2.73%)
USD 4.64
+0.26 (+7.60%)
USD 19.78
+1.31 (+8.78%)
Biggest Losers
Price 1 Week Change
USD 4.65
-1.72 (-22.69%)
USD 754.72
-31.60 (-3.29%)
USD 23.87
+0.45 (+1.57%)
USD 5.91
+0.28 (+4.10%)
USD 4.21
-0.04 (-0.83%)
Biggest Gainers
Price 1 Week Change
CAD 12.31
+0.57 (+5.55%)
CAD 45.39
+0.04 (+0.10%)
CAD 11.20
+0.59 (+6.01%)
CAD 19.46
-0.07 (-0.38%)
CAD 12.27
-0.14 (-1.21%)
Biggest Losers
Price 1 Week Change
CAD 7.21
+0.00 (+0.00%)
CAD 25.50
+0.53 (+1.93%)
CAD 7.37
+0.13 (+1.64%)
CAD 3.03
+0.00 (+0.00%)
CAD 9.04
+0.14 (+1.47%)
Biggest Gainers
Price 1 Week Change
GBX 518.60
+16.70 (+3.78%)
GBX 444.00
+6.60 (+1.61%)
GBX 513.50
-1.40 (-0.29%)
GBX 1,363.50
-33.00 (-2.50%)
GBX 69.34
-0.10 (-0.15%)
Biggest Losers
Price 1 Week Change
GBX 1,400.00
+54.00 (+3.82%)
GBX 2,166.00
-5.00 (-0.22%)
GBX 793.00
-18.00 (-2.17%)
GBX 516.20
+7.40 (+1.44%)
GBX 838.00
+6.00 (+0.72%)
Biggest Gainers
Price 1 Week Change
INR 230.50
-3.80 (-1.90%)
INR 164.65
-4.50 (-3.01%)
INR 259.95
-3.60 (-1.54%)
INR 136.05
-2.10 (-1.71%)
INR 3,129.95
-54.65 (-1.93%)
Biggest Losers
Price 1 Week Change
INR 295.90
-6.10 (-1.56%)
INR 3,466.40
-14.35 (-0.37%)
INR 1,399.05
+2.65 (+0.18%)
INR 4,436.40
+70.65 (+1.51%)
INR 1,891.10
-26.50 (-1.30%)
Ad

From the Investment Vault

Curated Articles based on your interest

Microsoft Corporation (MSFT: NYE) and OpenAI are currently involved in a legal dispute due to allegations of copyright infringement by Nicholas Basbanes and Nicholas Gage. They claim OpenAI's ChatGPT was trained by using their work. Previously, the New York Times made similar allegations in December 2023. These instances highlight a pattern of...

What Does the Downgrade Mean for Starbucks? Citigroup, a leading global bank, has recently downgraded its 12-month target for Starbucks Corporation (SBUX) from its previous value to USD 105 on May 1, 2024. This alteration to its prior forecast has brought the spotlight on Starbucks, eliciting questions about the company’s financial prospects,...

Apple Inc. (AAPL: NSD) faces a challenging phase marked by declining iPhone sales and heightened scrutiny from market analysts. Notably, Apple's stock has experienced a downturn, dropping over 1.5% in Thursday's trading session. Let's analyze these factors in more detail.   Impact of Downgraded Stock Rating on Apple: In recent...

Piper Jaffray Downgrades Apple Inc: What Does This Mean For Investors? On January 4th, 2024, Piper Jaffray Companies introduced waves into the tech sector with a downgrade of Apple Inc. (stocksymbolAAPL) from a Buy rating to Neutral. The adjusted target price dropped from $220 to $205, pointing to a potentially diminishing upside for the...

Analyst Ratings Coverage B. Riley Financial (Rank#34) has revised its target for AMC's stock, resulting in a lowered of the 12 month target price in the stock from USD 15 to USD 12. This adjustment suggests a less optimistic outlook for the stock's future performance.  The analyst also maintained  the "Neutral" rating on AMC. AMC Stock...

AMC

Moderna Stock: Is It Time to Jump In? Analyst Upgrade: Moderna (MRNA) stock saw a significant surge after an upgrade to 'Outperform' by Oppenheimer, with a new price target of $142 per share, indicating a potential over 40% gain from the previous closing price. What is Stock Target Advisor's View on Moderna Inc (MRNA)? Current State: Stock...

Analyst Ratings Coverage Barclays Capital (Rank#4) on Tuesday January 2nd, issued a research report on Apple's stock, downgrading the company to a "Underweight" rating from a "Equal Weight" rating.  The analyst also lowered the 12 month target forecast on the stock price to $160 from $166per share.  Barclays Capital blamed concerns of iPhone...

Nvidia (NVDA: NSD) is considered by Wall Street analysts as the top stock pick for 2024. The company is a leading provider of graphics processing units (GPUs) and artificial intelligence (AI) technology, offering a wide range of applications, from gaming and data centers to autonomous vehicles and AI research. Its strong market position indicates...

Apple (AAPL: NSD) has received permission to continue selling its latest smartwatches after a temporary pause on the import ban imposed by the Federal Trade Commission. This recent development is a significant relief for the company, as it allows them to continue offering their popular product to consumers. AAPL Ratings by Stock Target...

Cytokinetics Inc's stock (CYTK: NSD) surged by over 30% after positive Phase 2 trial results of its lead drug candidate, omecamtiv mecarbil, for treating HFpEF. This indicates investors' growing confidence in Cytokinetics's innovative approach to treating the condition. CYTK Ratings by Stock Target Advisor Stock Target...